52 results match your criteria: "and Instituto de Investigacion Sanitaria Hospital 12 de Octubre imas12[Affiliation]"

Objective: To assess the prognostic impact of a routine invasive strategy according to the frailty burden in patients with non-ST-segment elevation myocardial infarction (NSTEMI) from the MOSCA-FRAIL clinical trial.

Methods: The MOSCA-FRAIL trial randomized 167 frail patients, defined by a Clinical Frailty Scale (CFS) ≥ 4, with NSTEMI to an invasive or conservative strategy. The primary endpoint was the number of days alive and out of hospital (DAOH) one year after discharge.

View Article and Find Full Text PDF
Article Synopsis
  • The study assessed outcomes, resource use, and costs related to Chronic Obstructive Pulmonary Disease (COPD) by analyzing a cohort of patients who visited the emergency department in 2018.
  • In a sample of 2,384 COPD patients, the study found high mortality rates—23.4% within one year—and significant readmission rates, with costs totaling approximately €14.6 million.
  • The findings highlight the need for specialized programs to improve care for COPD patients due to their high mortality, readmission rates, and substantial economic burden on the healthcare system.
View Article and Find Full Text PDF

Risks and benefits of sharing patient information on social media: a digital dilemma.

Eur Heart J Digit Health

May 2024

Erasmus Medical Center, Cardiovascular Institute, Department of Cardiology, Rotterdam, The Netherlands.

Social media (SoMe) has witnessed remarkable growth and emerged as a dominant method of communication worldwide. Platforms such as Facebook, X (formerly Twitter), LinkedIn, Instagram, TikTok, and YouTube have become important tools of the digital native generation. In the field of medicine, particularly, cardiology, attitudes towards SoMe have shifted, and professionals increasingly utilize it to share scientific findings, network with experts, and enhance teaching and learning.

View Article and Find Full Text PDF
Article Synopsis
  • The MOSCA-FRAIL trial investigated treatment approaches for frail patients (aged ≥70) with non-ST-segment elevation myocardial infarction (NSTEMI) and found no significant difference in health outcomes after one year between invasive and conservative strategies.
  • Following extended follow-up until January 2023, the analysis of 167 patients indicated similar survival times and readmission rates, revealing that neither treatment significantly outperformed the other.
  • Overall, while initial outcomes suggested that invasive treatment might lead to shorter survival in the first year, the long-term results demonstrated inconclusive differences, highlighting the need for personalized treatment decisions in frail older adults.
View Article and Find Full Text PDF
Article Synopsis
  • Heart transplant recipients (HTr) are at greater risk for severe COVID-19, and a study analyzed their prognosis over the pandemic from February 2020 to October 2022.* -
  • Among 308 HTr studied, 39.2% were infected; those with pneumonia had significantly worse outcomes, with higher hospitalization and death rates compared to less severe cases.* -
  • Improvements in prognosis were noted over time, with reduced pneumonia (from 62% to 19%) and mortality (from 23% to 4%), attributed to factors like vaccination and early remdesivir treatment.*
View Article and Find Full Text PDF

Aims: Diabetes mellitus (diabetes) is common amongst patients with non-ST-segment elevation myocardial infarction (NSTEMI). We describe presentation, care, and outcomes of patients admitted with NSTEMI by diabetes status.

Methods And Results: Prospective cohort study including 2928 patients (1104 with prior diabetes, 1824 without) admitted to hospital with NSTEMI from 287 centres in 59 countries.

View Article and Find Full Text PDF

Aims: Women have historically been disadvantaged in terms of care and outcomes for non-ST-segment elevation myocardial infarction (NSTEMI). We describe patterns of presentation, care, and outcomes for NSTEMI by sex in a contemporary and geographically diverse cohort.

Methods And Results: Prospective cohort study including 2947 patients (907 women, 2040 men) with Type I NSTEMI from 287 centres in 59 countries, stratified by sex.

View Article and Find Full Text PDF

Background: To assess the diagnostic accuracy of the Mayo Clinic echocardiographic criteria for differentiating between constrictive pericarditis and restrictive cardiomyopathy.

Methods: We searched electronic databases for the date range from their inception to July 1, 2022. The index tests were the Mayo Clinic echocardiographic criteria.

View Article and Find Full Text PDF
Article Synopsis
  • The VIRGO study analyzed 3,572 young adults (ages 18-55) who experienced an acute myocardial infarction (AMI), focusing on the effects of obstructive sleep apnea (OSA) on health outcomes, particularly by sex.
  • About 49% of patients were identified as high risk for OSA, but only 4.7% had a prior diagnosis, highlighting a significant gap in awareness.
  • Women at high risk for OSA showed significantly worse physical and mental health outcomes compared to their male counterparts, suggesting they are more adversely affected by the condition following an AMI.
View Article and Find Full Text PDF

Background: Compatibility of DiamondTemp (DT) radiofrequency (RF) catheter with the Rhythmia mapping system has not been manufacturer-reported nor its tracking accuracy reported.

Methods: Consecutive patients undergoing macroreentrant atrial tachycardia ablation guided by Rhythmia and ablated using DT were prospectively enrolled. Following catheter configuration, ablation lines were performed and remapped to measure the RF tag to effective-ablation-line-center (RFT-ALC) distance.

View Article and Find Full Text PDF
Article Synopsis
  • A study evaluated the effectiveness of hypertonic saline solution (HSS) combined with furosemide against furosemide alone in treating acute decompensated heart failure (ADHF), using data from ten randomized controlled trials with over 3,000 patients.
  • Results showed that the combination treatment led to a significant decrease in hospital stay duration, weight, serum creatinine levels, and type-B natriuretic peptide levels, along with increased urine output and serum sodium levels, though quality of evidence varied.
  • While the findings support using HSS with furosemide for better outcomes in ADHF patients, more comprehensive studies are necessary to determine impacts on mortality and
View Article and Find Full Text PDF

Subclinical atherosclerosis and accelerated epigenetic age mediated by inflammation: a multi-omics study.

Eur Heart J

August 2023

Centro Nacional de Investigaciones Cardiovasculares (CNIC), Melchor Fernández Almagro, 3, 28029 Madrid, Spain.

Aims: Epigenetic age is emerging as a personalized and accurate predictor of biological age. The aim of this article is to assess the association of subclinical atherosclerosis with accelerated epigenetic age and to investigate the underlying mechanisms mediating this association.

Methods And Results: Whole blood methylomics, transcriptomics, and plasma proteomics were obtained for 391 participants of the Progression of Early Subclinical Atherosclerosis study.

View Article and Find Full Text PDF

Diabetes mellitus and aortic stenosis head to head: toward personalized medicine in patients with both pathologies.

Transl Res

September 2023

Department of Vascular Physiopathology, Hospital Nacional de Paraplejicos, Instituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), Spain. Electronic address:

Diabetes mellitus (DM) and calcific aortic stenosis (CAS) are common morbidities in the elderly, which are both chronic, progressive and often concomitant diseases. Several studies revealed that DM increases the risk of developing severe CAS, yet clear information about the relationship between both these diseases and the influence of DM on the progression of CAS is currently lacking. To evaluate the effect of DM on aortic valves and on the process of calcification, and to achieve better patient management in daily clinical practice, we analysed calcified and noncalcified valve tissue from patients with severe CAS, with or without DM.

View Article and Find Full Text PDF
Article Synopsis
  • This study is the first randomized clinical trial to compare invasive versus conservative treatment strategies for frail, older patients (≥70 years) with non-ST-segment elevation acute myocardial infarction (NSTEMI).
  • Conducted across 13 hospitals in Spain from 2017 to 2021, it included 167 patients and measured primary outcomes like days alive and out of the hospital (DAOH) and the rates of cardiac-related complications.
  • Results showed that while conservatively managed patients had slightly more DAOH (312 days) compared to those managed invasively (284 days), the difference was not statistically significant, and no major differences in mortality were found between the two groups. *
View Article and Find Full Text PDF

Background: The majority of NSTEMI burden resides outside high-income countries (HICs). We describe presentation, care, and outcomes of NSTEMI by country income classification.

Methods And Results: Prospective cohort study including 2947 patients with NSTEMI from 287 centres in 59 countries, stratified by World Bank country income classification.

View Article and Find Full Text PDF

Cancer is a multifactorial chronic illness caused by a combination of genetic and environmental factors. A tumor is more than just a collection of cancer cells, it also contains infiltrating and resident host cells that are constantly interacting with it. Innate lymphoid cells (ILCs) have been recently found to be within the tumor and its microenvironment in close relationship with cancer cells.

View Article and Find Full Text PDF

Aims: The European Society of Cardiology (ESC) EURObservational Research Programme (EORP) Non-ST-segment elevation myocardial infarction (NSTEMI) Registry aims to identify international patterns in NSTEMI management in clinical practice and outcomes against the 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without ST-segment-elevation.

Methods And Results: Consecutively hospitalised adult NSTEMI patients (n = 3620) were enrolled between 11 March 2019 and 6 March 2021, and individual patient data prospectively collected at 287 centres in 59 participating countries during a two-week enrolment period per centre. The registry collected data relating to baseline characteristics, major outcomes (in-hospital death, acute heart failure, cardiogenic shock, bleeding, stroke/transient ischaemic attack, and 30-day mortality) and guideline-recommended NSTEMI care interventions: electrocardiogram pre- or in-hospital, pre-hospitalization receipt of aspirin, echocardiography, coronary angiography, referral to cardiac rehabilitation, smoking cessation advice, dietary advice, and prescription on discharge of aspirin, P2Y12 inhibition, angiotensin converting enzyme inhibitor (ACEi)/angiotensin receptor blocker (ARB), beta-blocker, and statin.

View Article and Find Full Text PDF

CD69 expression on regulatory T cells protects from immune damage after myocardial infarction.

J Clin Invest

November 2022

Vascular Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.

Article Synopsis
  • The study examines the role of T cells, particularly CD69+ Tregs, in managing immune responses and cardiac function after a heart attack (myocardial infarction).
  • Analysis of 283 patients showed that overexpression of CD69 on Tregs is linked to improved survival rates.
  • Experiments in mice revealed that CD69+ Tregs reduce harmful inflammation and improve heart function, suggesting CD69 as a potential biomarker and therapeutic target to reduce heart failure risk post-MI.
View Article and Find Full Text PDF

HIV and Schistosoma Co-Exposure Leads to Exacerbated Pulmonary Endothelial Remodeling and Dysfunction Associated with Altered Cytokine Landscape.

Cells

August 2022

Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid and Instituto de Investigación Sanitaria Gregorio Marañón, Centro de Investigación Biomédica en Red Enfermedades Respiratorias, 28040 Madrid, Spain.

HIV and Schistosoma infections have been individually associated with pulmonary vascular disease. Co-infection with these pathogens is very common in tropical areas, with an estimate of six million people co-infected worldwide. However, the effects of HIV and Schistosoma co-exposure on the pulmonary vasculature and its impact on the development of pulmonary vascular disease are largely unknown.

View Article and Find Full Text PDF

Pediatric Infective Endocarditis: A Literature Review.

J Clin Med

June 2022

Servicio de Cardiología, Hospital Universitario Gregorio Marañón, Calle Doctor Esquerdo, 46, 28007 Madrid, Spain.

Article Synopsis
  • * Diagnosis has become more effective thanks to advanced imaging techniques, but the process is still complex.
  • * Early antibiotic treatment is crucial and should be tailored based on the specific microorganisms and risk factors, as complications frequently lead to significant health issues; most research has focused on adults, limiting its applicability to children.
View Article and Find Full Text PDF

New 3-Dimensional Volumetric Ultrasound Method for Accurate Quantification of Atherosclerotic Plaque Volume.

JACC Cardiovasc Imaging

June 2022

Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain; The Zena and Michael A. Wiener Cardiovascular Institute/Marie-Josée and Henry R. Kravis Center for Cardiovascular Health, Mount Sinai School of Medicine, New York, New York, USA. Electronic address:

Background: Carotid and femoral plaque burden is a recognized biomarker of cardiovascular disease risk. A new electronic-sweep 3-dimensional (3D)-matrix transducer method can improve the functionality and image quality of vascular ultrasound atherosclerosis imaging.

Objectives: This study aimed to validate this method for plaque volume measurement in early and intermediate-advanced plaques in the carotid and femoral territories.

View Article and Find Full Text PDF

Time trends in the epidemiology of nonrheumatic aortic valve disease in Spain, 2003-2018.

Rev Esp Cardiol (Engl Ed)

December 2022

Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain; Servicio de Cardiología, Hospital Universitario 12 de Octubre and Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares (CIBERCV), Spain; Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain. Electronic address:

Introduction And Objectives: The impact of therapeutic improvements in nonrheumatic aortic valve disease (NRAVD) has been assessed at the patient level but not in the whole population with the disease. Our objective was to assess temporal trends in hospitalization rates, treatment and fatality rates in patients with a main or secondary NRAVD diagnosis.

Methods: Retrospective analysis of administrative claims from patients hospitalized with a main or secondary NRAVD diagnosis between 2003 and 2018 in Spain.

View Article and Find Full Text PDF